We'd be happy to help you determine whether a microdosing approach aligns with your health goals
Repatha is generally not recommended for use during pregnancy as its effects on an unborn baby are unknown
insulin should be adjusted gradually with careful glucose monitoring
Our study detected a robust genetic association with GLP1 medication weight loss efficacy and associated side effects
It offers a pharmacological method to achieve weight loss without invasive procedures
Figure 2: Categorical weight loss of either 5%, 10%, or 15% in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo